Publication | Closed Access

PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3β pathway☆

CardiomyopathyHeart FailureMolecular PhysiologyCardiovascular DiseaseMedicineParp Inhibition PreventsCardiovascular PharmacologyCardiologyPharmacologyCell BiologyCell SignalingProtein Kinase C/glycogenCardiac PathologyMyocardial Infarction